Diaceutics (LON:DXRX) Insider Sells £475,000 in Stock

Diaceutics PLC (LON:DXRX – Get Free Report) insider Jordan Clark sold 250,000 shares of the business’s stock in a transaction dated Thursday, November 12th. The stock was sold at an average price of GBX 190, for a total value of £475,000.

Diaceutics Stock Down 0.5%

DXRX stock opened at GBX 194 on Monday. The stock has a market capitalization of £164.85 million, a P/E ratio of -606.25 and a beta of 0.88. The company has a current ratio of 2.55, a quick ratio of 9.92 and a debt-to-equity ratio of 5.40. Diaceutics PLC has a 12 month low of GBX 125 and a 12 month high of GBX 210. The firm has a 50-day moving average price of GBX 189.12 and a 200-day moving average price of GBX 160.98.

Diaceutics (LON:DXRX – Get Free Report) last announced its quarterly earnings results on Tuesday, September 22nd. The company reported GBX (3.27) earnings per share (EPS) for the quarter. Diaceutics had a negative net margin of 0.66% and a negative return on equity of 0.68%. As a group, equities research analysts anticipate that Diaceutics PLC will post 1.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reaffirmed a “buy” rating and set a GBX 215 target price on shares of Diaceutics in a research note on Tuesday, November 10th. Two analysts have rated the stock with a Buy rating. Based on data from MarketBeat, Diaceutics has a consensus rating of “Buy” and a consensus price target of GBX 215.

Check Out Our Latest Stock Analysis on DXRX

Diaceutics Company Profile

(Get Free Report)

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.

Recommended Stories

Insider Buying and Selling by Quarter for Diaceutics (LON:DXRX)

Receive News & Ratings for Diaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diaceutics and related companies with MarketBeat.com's FREE daily email newsletter.